Samantha Keow, BSc Credit: LinkedIn Abrocitinib serves as an efficacious therapy for individuals with moderate-to-severe atopic dermatitis (MtS-AD) who either fail to respond to, are unable to tolerate, or report adverse events (AEs) with biologic treatments, according to new findings.1 These results were the conclusion of new research led by Samantha Keow, BSc, from the […]
Articles By Angela Ballard, RN Published On: Jun 17, 2024 Last Updated On: Jun 17, 2024 While there have been advances in atopic dermatitis (AD) treatment options, including new medications, many patients still face challenges in obtaining these treatments, even when they’ve been prescribed by their doctor. A new study from the National Eczema Association […]
Facial eczema affects the health of a range of livestock including sheep, cattle, deer, goats and alpacas. Photo / Brett Phibbs Crown Research Institute Scion is joining the fight against facial eczema and its effect on New Zealand’s pastoral sector. Scion will contribute its economic modelling knowledge to Eliminating Facial Eczema Impacts, a collaborative programme […]
According to the French Institute of Health and Medical Research, INSERM, atopic dermatitis, also known as atopic eczema, is “a chronic inflammatory skin disease, … characterized by dry skin associated with eczema-like lesions (redness and itching, vesicles, oozing and crusting) that develop in flare-ups.” The scientific research organization points the finger at genetic and environmental […]
